Mi-Hyun Kim

TL;DR: A centrifugal-force-based size-selective CTC isolation platform that can isolate and enumerate CTCs from whole blood within 30 s with high purity is proposed, which should greatly improve downstream molecular analyses of captured C TCs.

TL;DR: The clinical significance and uniqueness of CTCs and ctDNA from NSCLC patients are examined, isolation and detection methods developed to analyze each type of circulating biomarker, and examples of clinical studies of potential applications for early diagnosis, prognosis, treatment monitoring, and prediction of resistance to therapy are discussed.

TL;DR: The results suggest a potential role of CTCs as an early diagnostic biomarker of gastric cancer in patients who underwent gastrectomy and explore their clinical usefulness in the early diagnosis of Gastric cancer.

TL;DR: The ability of Exodisc-B to provide a rapid, sensitive, and point-of-care-type method for extracting intact EVs from small volumes of clinical blood samples for disease diagnosis and monitoring is demonstrated.

TL;DR: It is thought that this kind of adenocarcinoma arising through mucous columnar cell change belongs to non-terminal respiratory unit typeAdenocARCinoma, and mucous Columnar Cell change is a precursor lesion of pulmonary adenOCarcinomas.